Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TRIPLE TRADES -- Ignore unavailable to you. Want to Upgrade?

To: Tweets Boar Hog who wrote (1665)	9/30/2021 2:03:46 PM
From: Jack of All Trades	Respond to of 4446

Gamma from options...

To: Tweets Boar Hog who wrote (1665)	10/1/2021 9:21:38 AM
From: robert b furman	Read Replies (2) \| Respond to of 4446

Tweets, This market launch, while on the precipice, is being the result of Merck's new aniviral Ridgeback. A pill regimen that takes five days to recover from Covid on average 1.3 days and it prevents hospitalization in over 50.2 percent of people taking ridgeback. More importantly it will put the death strike on Biden's insane over reach on his jab mandate: Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection